Search Results 361-370 of 17608 for Glucocorticoids

  1. Biomarker-guided CNI substitution in Kidney Transplantation Assessment - Mayo Clinic

    Glucocorticoid, with a minimum dose equivalent to 5mg of prednisone per day. Nested Randomized Control Trial (RCT): 1. Subject must be able to understand and ...

  2. https://www.mayoclinic.org/chinese_patient_consumer_faq.xml

  3. A Study to Evaluate Effectiveness and Quality of Life Outcomes of Daratumumab in Relapsed/Refractory Multiple Myeloma Patients - Mayo Clinic

    Prior or concurrent topical or localized glucocorticoid therapy to treat non-malignant comorbid disorders is permitted. ECOG performance status 0, 1, or 2 ...

  4. Endocrinology - Doctors - Mayo Clinic

    Endocrinology at Mayo Clinic offers treatment and specialty care for people with a wide range of rare and common endocrine disorders.

  5. Ozone air purifiers: Can they improve asthma symptoms? - Mayo Clinic

    Ozone-induced oxidative stress, neutrophilic airway inflammation, and glucocorticoid resistance in asthma. Frontiers in Immunology. 2021; doi:10.3389/fimmu ...

  6. A Study to Test the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer - Mayo Clinic

    Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...

  7. Endocrinology - Clinical trials

    [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

  8. Thyroid eye disease clinic — The Mayo Clinic Model

    Abbreviations used: DON, dysthyroid optic neuropathy; GO, Graves' orbitopathy; IVGC, intravenous glucocorticoid; and, XRT, external beam radiation therapy.

  9. Safety And Feasibility Of Novel Therapy For Duodenal Mucosal Regeneration For Type II Diabetes (REGENT-1-US) - Mayo Clinic

    Use of systemic glucocorticoids (excluding topical or ophthalmic application or inhaled forms) for more than 10 consecutive days within 12 weeks prior to the ...

  10. A Study To Evaluate The Effect Of The Transient Receptor Potential Vanilloid 4 (TRPV4) Channel Blocker, GSK2798745, On Pulmonary Gas Transfer And Respiration In Patients With Congestive Heart Failure - Mayo Clinic

    ... glucocorticoids as well as oxygen therapy. Use of a listed prohibited medication within the restricted timeframe relative to the first dose of study ...